Immunolocalization of the calcium-sensing receptor in developing human kidney

Pediatric Research

Volumn 74, Issue 2, 2013, Pages 133-140

  Crisi, Giovanna M ^a   Rockwell, Gary F ^a   Braden, Gregory L ^a   Campfield, Thomas J ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SENSING RECEPTOR;

ARTICLE; DIURESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; KIDNEY DEVELOPMENT; KIDNEY DISTAL TUBULE; MALE; NEWBORN; ONTOGENY; OSMOREGULATION; PREMATURITY; PRIORITY JOURNAL;

EID: 84881235767     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.72     Document Type: Article

References (37)

1. Rauch F, Schoenau E. Skeletal development in premature infants: a review of bone physiology beyond nutritional aspects. Arch Dis Child Fetal Neonatal Ed 2002;86:F82-5.
2. Hufnagle KG, Khan SN, Penn D, Cacciarelli A, Williams P. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics 1982;70:360-3.
3. Jacinto JS, Modanlou HD, Crade M, Strauss AA, Bosu SK. Renal calcification incidence in very low birth weight infants. Pediatrics 1988;81: 31-5.
4. Downing GJ, Egelhoff JC, Daily DK, Thomas MK, Alon U. Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years. J Pediatr 1992;120(4 Pt 1):599-604.
5. Ezzedeen F, Adelman RD, Ahlfors CE. Renal calcification in preterm infants: pathophysiology and long-term sequelae. J Pediatr 1988;113: 532-9.
6. Kist-van Holthe JE, van Zwieten PH, Schell-Feith EA, et al. Is nephrocalcinosis in preterm neonates harmful for long-term blood pressure and renal function? Pediatrics 2007;119:468-75.
7. Narendra A, White MP, Rolton HA, et al. Nephrocalcinosis in preterm babies. Arch Dis Child Fetal Neonatal Ed 2001;85:F207-13.
8. Gimpel C, Krause A, Franck P, Krueger M, von Schnakenburg C. Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants. Pediatr Int 2010;52:51-6.
9. Campfield T, Braden G, Flynn-Valone P, Powell S. Effect of diuretics on urinary oxalate, calcium, and sodium excretion in very low birth weight infants. Pediatrics 1997;99:814-8.
10. Schell-Feith EA, Kist-van Holthe JE, Conneman N, et al. Etiology of nephrocalcinosis in preterm neonates: association of nutritional intake and urinary parameters. Kidney Int 2000;58:2102-10.
11. Vikse BE, Irgens LM, Leivestad T, Hallan S, Iversen BM. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol 2008;19: 151-7.
12. White SL, Perkovic V, Cass A, et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis 2009;54:248-61.
13. Riccardi D, Brown EM. Physiology and pathophysiology of the calciumsensing receptor in the kidney. Am J Physiol Renal Physiol 2010;298: F485-99.
14. Di Stefano A, Wittner M, Nitschke R, et al. Effects of parathyroid hormone and calcitonin on Na+, Cl-, K+, Mg2+ and Ca2+ transport in cortical and medullary thick ascending limbs of mouse kidney. Pflugers Arch 1990;417:161-7.
15. Hebert SC, Brown EM, Harris HW. Role of the Ca(2+)-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 1997;200(Pt 2): 295-302.
16. Desfleurs E, Wittner M, Simeone S, et al. Calcium-sensing receptor: regulation of electrolyte transport in the thick ascending limb of Henle's loop. Kidney Blood Press Res 1998;21:401-12.
17. Varghese J, Rich T, Jimenez C. Benign familial hypocalciuric hypercalcemia. Endocr Pract 2010;6:1-16.
18. Sands JM, Naruse M, Baum M, et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 1997;99:1399-405.
19. Procino G, Mastrofrancesco L, Mira A, et al. Aquaporin 2 and apical calcium-sensing receptor: new players in polyuric disorders associated with hypercalciuria. Semin Nephrol 2008;28:297-305.
20. Lam GS, Asplin JR, Halperin ML. Does a high concentration of calcium in the urine cause an important renal concentrating defect in human subjects? Clin Sci 2000;98:313-9.
21. Bergsland KJ, Coe FL, Gillen DL, Worcester EM. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol 2009;297:F1017-23.
22. Renkema KY, Bindels RJ, Hoenderop JG. Role of the calcium-sensing receptor in reducing the risk for calcium stones. Clin J Am Soc Nephrol 2011;6:2076-82.
23. Chattopadhyay N, Baum M, Bai M, et al. Ontogeny of the extracellular calcium-sensing receptor in rat kidney. Am J Physiol 1996;271(3 Pt 2): F736-43.
24. Riccardi D, Hall AE, Chattopadhyay N, Xu JZ, Brown EM, Hebert SC. Localization of the extracellular Ca2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol 1998;274(3 Pt 2):F611-22.
25. Hiatt MJ, Ivanova L, Toran N, Tarantal AF, Matsell DG. Remodeling of the fetal collecting duct epithelium. Am J Pathol 2010;176:630-7.
26. Loupy A, Ramakrishnan SK, Wootla B, et al. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J Clin Invest 2012;122:3355-67.
27. Ward DT, Maldonado-Pérez D, Hollins L, Riccardi D. Aminoglycosides induce acute cell signaling and chronic cell death in renal cells that express the calcium-sensing receptor. J Am Soc Nephrol 2005;16: 1236-44.
28. Ho C, Conner DA, Pollak MR, et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 1995;11:389-94.
29. Kos CH, Karaplis AC, Peng JB, et al. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest 2003;111:1021-8.
30. Kovacs CS, Ho-Pao CL, Hunzelman JL, et al. Regulation of murine fetalplacental calcium metabolism by the calcium-sensing receptor. J Clin Invest 1998;101:2812-20.
31. Rodd C, Goodyer P. Hypercalcemia of the newborn: etiology, evaluation, and management. Pediatr Nephrol 1999;13:542-7.
32. Crisi GM, Marconi SA, Rockwell GF, Braden GL, Campfield TJ. Immunolocalization of CD44 and osteopontin in developing human kidney. Pediatr Res 2009;65:79-84.
33. Goldsmith PK, Fan G, Miller JL, Rogers KV, Spiegel AM. Monoclonal antibodies against synthetic peptides corresponding to the extracellular domain of the human Ca2+ receptor: characterization and use in studying concanavalin A inhibition. J Bone Miner Res 1997;12: 1780-8.
34. Kifor O, Moore FD Jr, Wang P, et al. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996;81: 1598-606.
35. Fleming S, Lindop GB, Gibson AA. The distribution of epithelial membrane antigen in the kidney and its tumours. Histopathology 1985;9: 729-39.
36. Holm-Nielsen P, Pallesen G. Expression of segment-specific antigens in the human nephron and in renal epithelial tumors. APMIS Suppl 1988;4: 48-55.
37. Eccles MR, He S, Legge M, et al. PAX genes in development and disease: the role of PAX2 in urogenital tract development. Int J Dev Biol 2002;46: 535-44.